Connect with us

Health

World Marks 37th World AIDS Day as Funding Cuts Raise Fears of Setbacks in Global Fight Against HIV

Published

on

An estimated 40.8 million people are living with HIV worldwide, and the virus claimed about 630,000 lives last year, according to new global health figures released as the world observed the 37th World AIDS Day on Sunday. The annual commemoration, held every 1 December since 1988, brings together scientists, health workers, families and advocates to honour victims and renew the push to end one of the deadliest epidemics in modern history.

Since the start of the crisis, HIV has infected about 91.4 million people and caused approximately 44.1 million deaths. Despite decades of scientific advancement, experts warn that progress could be at risk as several major donor nations scale back support for international HIV programmes.

The global response to HIV began gaining momentum in the early 1980s, when US health officials identified a mysterious and fatal illness among young gay men. The disease, later understood to be caused by HIV, soon spread across different communities, from people who used drugs to haemophiliacs and blood transfusion recipients. Europe launched its first AIDS surveillance system in 1984, and by late 1985 HIV testing became available in the UK.

A turning point came in 1996 with the introduction of highly active antiretroviral therapy, or HAART, a three-drug combination that suppressed the virus and restored immune function. This breakthrough sharply reduced AIDS-related deaths in countries able to afford the treatment and shifted HIV from a near-certain death sentence to a chronic but manageable condition.

In 2003, the United States introduced the President’s Emergency Plan for AIDS Relief (PEPFAR), a landmark $15 billion programme aimed at high-burden countries. As of 2025, PEPFAR has been credited with saving more than 26 million lives across 50 nations, making it the largest single-disease global health programme in history.

See also  How Sleeping Less than 7 Hours a Night Can Lead to Weight Gain

Scientific progress continued into the next decade. In 2011, researchers confirmed that antiretroviral therapy significantly reduces the risk of transmitting HIV. A year later, US regulators approved Truvada as the first drug for pre-exposure prophylaxis (PrEP), followed by the EU in 2016. PrEP has since become a cornerstone of prevention, shown to reduce infection risk from sex by about 99% and from injections by roughly 74%. These tools helped drive HIV diagnoses among gay and bisexual men in the UK down by two-thirds between 2015 and 2020.

But global gaps remain. The UN’s 90-90-90 targets—set for 2020 and aimed at ensuring that 90% of people with HIV know their status, receive treatment, and achieve viral suppression—were fully met by only 19 countries. Sweden was the first to reach the milestones in 2016.

Recent advances, including a twice-yearly PrEP injection approved in the EU in 2024, have been hailed as potential game-changers. Plans are underway to bring generic versions to lower-income nations by 2027.

This year, however, health agencies have sounded the alarm over abrupt US aid freezes and funding reductions from several European governments, including the UK, Germany and France. Experts warn the cuts threaten to reverse gains in HIV prevention and treatment, especially in Africa, which accounts for more than two-thirds of all infections.

As World AIDS Day is marked once again, global health leaders stress that decades of progress cannot be sustained without consistent international support.

Health

Congenital Infections Linked to Higher Risks of Autism and Intellectual Disability

Published

on

Children born with certain infections acquired during pregnancy face substantially higher risks of autism and intellectual disability later in life, according to a study of more than 3.7 million people in Sweden.

Researchers found that children with congenital infections were about three times more likely to be diagnosed with autism and more than seven times more likely to receive a diagnosis of intellectual disability than those without such infections.

The findings suggest that infections transmitted from a pregnant woman to her foetus may have lasting effects on brain development, although the study identifies an association rather than proving that the infections directly cause autism or intellectual disability.

The research focused on TORCH infections, a group that includes syphilis, rubella, toxoplasmosis, cytomegalovirus and herpesvirus. These infections can cross the placenta and affect the developing foetus, potentially increasing the risk of miscarriage, stillbirth and other pregnancy complications.

“Although these congenital infections are rare, some of them can be prevented, which makes them important from a public health perspective,” said Reneé Gardner of the Department of Global Public Health at Karolinska Institutet, who contributed to the study.

The researchers examined people born in Sweden between 1987 and 2021 and followed them for up to 30 years. Among the 3.7 million participants, 975 had been diagnosed with a congenital TORCH infection.

Although congenital infections accounted for only a small proportion of autism cases across the population, the risk among affected children was considerably higher. The researchers estimated that about one in five children born with a TORCH infection could later develop autism.

See also  Workplace Gratitude Gains Ground as a Tool for Morale and Mental Wellbeing

The study also found elevated risks of intellectual disability across different levels of severity. The risk of severe to profound intellectual disability was as much as 30 times higher among children with a congenital infection than among those without one.

The researchers found evidence of an impact on educational outcomes even among people who were not diagnosed with autism or intellectual disability. A total of 420 participants with a TORCH infection showed poor school performance without receiving either diagnosis.

Congenital cytomegalovirus, or CMV, is the most common of these infections globally and affects roughly one in 150 newborns. Its burden is substantially greater in low- and middle-income countries.

The researchers said the findings highlight the importance of prevention, particularly in regions where these infections are more common. They pointed to vaccination programmes and other preventive measures as important tools for reducing congenital infections.

They also called for improved identification of affected newborns. Current screening systems, including those used in Sweden, may miss asymptomatic infections because universal screening for TORCH infections is not routinely carried out.

The authors said stronger screening and prevention strategies could help identify children at risk earlier and improve long-term support and care.

Continue Reading

Health

AI Chatbots Make Faster, Less Nuanced Kidney Transplant Decisions Than Doctors

Published

on

Artificial intelligence chatbots may make faster and more confident decisions than human doctors when determining which patient should receive a life-saving kidney transplant, but a new study found that the systems often rely on fewer factors and show less sensitivity to the ethical complexity of such choices.

Researchers from Penn State University in the United States compared decisions made by large language models (LLMs) with choices made by people in earlier studies on kidney allocation. The researchers presented AI models with hypothetical cases based on existing datasets in which human participants had previously chosen between two patients competing for a single available kidney.

The patients were described using characteristics including age, health and drinking habits. Both were considered eligible for the transplant, requiring the decision maker to determine which patient should receive the available organ.

The researchers tested the AI systems in several ways. Some scenarios focused on individual characteristics, while others combined several traits to examine how the models handled competing considerations. In some tests, participants and AI systems were also given the option of flipping a coin, allowing researchers to assess indecision as part of moral decision-making.

Human participants generally placed greater importance on age, often favouring younger patients over older patients. Many of the AI models, however, placed greater weight on lower alcohol consumption.

Hadi Hosseini, the study’s lead researcher at Penn State University, said the findings showed that AI chatbots can diverge from human values when weighing characteristics of patients.

The researchers found that human decisions tended to consider several factors together and were more sensitive to context. LLMs, by contrast, frequently focused on a single characteristic when making their choices.

See also  New Study Finds Human Cognitive Abilities Peak Between Ages 55 and 60

Another difference involved uncertainty. Human participants were more likely to recognise that organ allocation can involve competing ethical considerations and that there may not be one objectively correct answer. AI models generally showed little hesitation and committed to one choice.

John Dickerson, chief executive officer of Mozilla.ai and a collaborator on the study, said humans recognise ambiguity when allocating scarce resources and use debate to shape how such decisions are made.

The findings come as AI systems are increasingly being used in healthcare for clinical workflows, diagnosis, treatment planning and decisions involving limited medical resources.

The researchers said kidney allocation presents a particularly important test because decisions over deceased-donor and living-donor organs involve medical, ethical and moral considerations.

Hosseini said the ethical stakes are high because decisions involving organ allocation can directly affect patients’ lives. He stressed that the study was not intended to encourage replacing professional medical judgment with AI.

Instead, the researchers said understanding how AI systems behave in high-stakes situations is becoming increasingly important as individuals, organisations and businesses use AI to make decisions or provide recommendations.

Continue Reading

Health

Frankfurt Issues Malaria Warning After Six Cases Reported Since July

Published

on

Health authorities in Frankfurt have warned residents and people working near the city’s airport to seek medical advice if they develop an unexplained fever after six malaria cases were reported in the city since July.

Two of the cases have been fatal, while two additional infections have recently been identified in the Schwanheim district, which is located close to Frankfurt Airport. The city’s public health authority is investigating whether the latest cases are connected.

Several of the recent infections have involved airport employees. Authorities suspect that mosquitoes capable of transmitting malaria may occasionally arrive in Germany on aircraft travelling from regions where the disease is widespread. If the insects survive and later bite people, they can potentially transmit the infection.

Malaria is a tropical disease transmitted through the bite of an infected mosquito. It is not normally spread directly from one person to another.

Frankfurt’s health authority said early diagnosis is important because malaria can initially resemble common illnesses such as influenza or a cold. Typical symptoms include fever, chills, headaches, pain in the limbs and gastrointestinal problems.

The Robert Koch Institute has warned that these symptoms can sometimes be mistaken for flu-like illnesses or stomach infections. The most dangerous form of the disease is malaria tropica, caused by the Plasmodium falciparum parasite. Without prompt diagnosis and treatment, it can become life-threatening.

People who live, work or spend significant amounts of time near Frankfurt Airport have been advised to consult a doctor if they develop unexplained fever. They should tell medical staff that they live or have recently spent time in the area around the airport.

See also  Cannabis and Cocaine Lead Drug Use in EU, Synthetic Substances Pose Growing Threat

The city’s public health authority is also providing information through a telephone hotline, available from 9am to 6pm on 069/212-30030.

Residents can take measures to reduce the risk of mosquito bites by using insect repellents and wearing clothing that covers the skin. Insect nets can also provide protection. Repellents containing DEET or icaridin are among the products recommended by Germany’s Federal Foreign Office.

Cases of so-called airport malaria remain rare in Germany. Research cited by the Robert Koch Institute indicates that more than 99% of malaria cases recorded in Europe are acquired in endemic regions outside the continent.

Between 1969 and early 2024, databases recorded 145 malaria cases in which patients were infected within Europe. More than two-thirds were classified as airport malaria. France recorded 52 cases, Belgium 19 and Germany nine, including eight in Frankfurt and one in Munich.

The two people recently infected in Frankfurt’s Schwanheim district are receiving hospital treatment, according to the city authorities.

The latest cases have prompted renewed attention to the possibility of malaria transmission in areas surrounding international airports, particularly when unexplained fever occurs without a recent trip to a malaria-endemic country.

Continue Reading

Trending